Background: The literature on antipsychotic medication in psychosis lack systematization of
the empirical knowledge base on patients' subjective experiences of using antipsychotic …

Purpose Neuroleptic (antipsychotic) drugs reduce psychotic symptoms, but how they
achieve these effects and how the drugs' effects are experienced by people who take them …

Background: Antipsychotic medication is currently the treatment of choice for psychosis, but
few studies directly survey the first-hand experience of recipients. Objective: To ascertain the …

Pharmacists have a contribution to make in improving optimising medication use for people
on antipsychotic medication. The rates of prescribing antipsychotics have increased in …

Objectives Our objectives were threefold:(1) describe a collaborative, theoretically driven
approach to co-designing complex interventions;(2) demonstrate the implementation of this …

Aim Many individuals with schizophrenia discontinue initially prescribed antipsychotics.
Knowledge on reasons for discontinuation among individuals with first‐episode …

Background Severe mental illness (SMI) incorporates schizophrenia, bipolar disorder, non-
organic psychosis, personality disorder or any other severe and enduring mental health …

Background: Based on a collective action from a number of Norwegian user organizations
for mental health, the Norwegian government demanded the regional health authorities to …

Background: Prescribing drugs for psychosis (antipsychotics) is challenging due to high
rates of poor treatment outcomes, which are in part explained by an individual's genetics …

Background Individuals with serious mental illness (SMI) are more likely to experience
functional decline, low well-being, comorbidities, shorter lifespan, and diminished quality of …